by John Lockwood | Oct 27, 2016
On October 17th, FDA announced that over $23 million in grants will be given to 21 new clinical trial research grants for development work in new therapies/devices for rare diseases over the next four years. The grants were awarded through the Orphan Products...
by John Lockwood | Jun 22, 2016
Pearl Pathways invites you to look over a final guidance just released by the FDA Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.” This encourages...